Impact of Highly Active Antiretroviral Therapy on Chronic Hepatitis B Serological Markers among Senegalese HIV Co-infected Children.

Ba, Abou; Ndiaye, Fatou K; Djeng, Yaay J; Cames, Cecile; Diack, Aminata; N'diaye, Ousmane

Ba, Abou; Ndiaye, Fatou K; Djeng, Yaay J; Cames, Cecile; Diack, Aminata; N'diaye, Ousmane.

Afiliação

Ba A; Centre Hospitalier National d'Enfants Albert Royer, BP: 25755-Fann, Dakar, Senegal.
Ndiaye FK; Centre Hospitalier National d'Enfants Albert Royer, BP: 25755-Fann, Dakar, Senegal.
Djeng YJ; Centre Hospitalier National d'Enfants Albert Royer, BP: 25755-Fann, Dakar, Senegal.
Cames C; Institut de Recherche pour le Développement (IRD), UMI233 IRD, INSERM U1175, Université de Montpellier, Montpellier, France.
Diack A; Centre Hospitalier National d'Enfants Albert Royer, BP: 25755-Fann, Dakar, Senegal.
N'diaye O; Centre Hospitalier National d'Enfants Albert Royer, BP: 25755-Fann, Dakar, Senegal.

Int J MCH AIDS ; 8(2): 131-137, 2019.

Article em En | MEDLINE | ID: mdl-31824751

Palavras-chave

Children; HBV infection; HIV infection; Immunology; Senegal; Serological markers; Serprvalence; Virology; antiretroviral therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Int J MCH AIDS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Senegal

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google